FIGURE 4.
5-year overall survival of patients initiating first-line TKI treatment for CML between 2011 and June 2020. CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.